Effects of COVID-19 Pandemic on Voluntary Medical Male Circumcision Services for HIV Prevention, Sub-Saharan Africa, 2020.
2019 novel coronavirus disease
COVID-19
HIV prevention
HIV/AIDS
SARS-CoV-2
coronavirus disease
impacts of COVID-19
respiratory infections
severe acute respiratory syndrome coronavirus 2
sub-Saharan Africa
viruses
voluntary medical male circumcision
zoonoses
Journal
Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155
Informations de publication
Date de publication:
12 2022
12 2022
Historique:
entrez:
11
12
2022
pubmed:
12
12
2022
medline:
15
12
2022
Statut:
ppublish
Résumé
Beginning in March 2020, to reduce COVID-19 transmission, the US President's Emergency Plan for AIDS Relief supporting voluntary medical male circumcision (VMMC) services was delayed in 15 sub-Saharan African countries. We reviewed performance indicators to compare the number of VMMCs performed in 2020 with those performed in previous years. In all countries, the annual number of VMMCs performed decreased 32.5% (from 3,898,960 in 2019 to 2,631,951 in 2020). That reduction is largely attributed to national and local COVID-19 mitigation measures instituted by ministries of health. Overall, 66.7% of the VMMC global annual target was met in 2020, compared with 102.0% in 2019. Countries were not uniformly affected; South Africa achieved only 30.7% of its annual target in 2020, but Rwanda achieved 123.0%. Continued disruption to the VMMC program may lead to reduced circumcision coverage and potentially increased HIV-susceptible populations. Strategies for modifying VMMC services provide lessons for adapting healthcare systems during a global pandemic.
Identifiants
pubmed: 36502454
doi: 10.3201/eid2813.212455
pmc: PMC9745243
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
S262-S269Références
PLoS One. 2021 Dec 23;16(12):e0260820
pubmed: 34941876
BMJ Open. 2018 Sep 1;8(8):e021835
pubmed: 30173159
PLoS One. 2018 Jul 18;13(7):e0199453
pubmed: 30020940
Vaccine. 2020 Sep 3;38(39):6078-6079
pubmed: 32773245
PLoS Med. 2005 Nov;2(11):e298
pubmed: 16231970
J Infect. 2020 Oct;81(4):625-633
pubmed: 32795481
J Acquir Immune Defic Syndr. 2014 Jul 1;66 Suppl 2:S193-9
pubmed: 24918595
Ethiop J Health Sci. 2022 Jan;32(1):37-44
pubmed: 35250215
Front Microbiol. 2020 Jun 18;11:1476
pubmed: 32625198
Lancet. 2007 Feb 24;369(9562):643-56
pubmed: 17321310
PLoS One. 2017 Mar 16;12(3):e0174466
pubmed: 28301578
Pan Afr Med J. 2021 Nov 24;40:180
pubmed: 35018213
Lancet HIV. 2020 Sep;7(9):e629-e640
pubmed: 32771089
Diabetes Metab Syndr. 2020 Nov-Dec;14(6):1809-1814
pubmed: 32956925
Lancet. 2007 Feb 24;369(9562):657-66
pubmed: 17321311
Emerg Microbes Infect. 2020 Dec;9(1):1300-1308
pubmed: 32458760
JAMA Netw Open. 2021 Dec 1;4(12):e2138038
pubmed: 34878546
HIV AIDS (Auckl). 2014 Oct 08;6:139-46
pubmed: 25336991